Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |